B. Meibohm

B. Meibohm, Pradeep B. Lukka, Santosh Wagh, 2019, Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases.

Real-time PCR-based genotyping assay for CXCR2 polymorphisms.

B. Meibohm, C. R. Yates, P. Song, 2004, Clinica chimica acta; international journal of clinical chemistry.

Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology

B. Meibohm, Lei Diao, 2018, Current Pharmacology Reports.

Drug-Drug Interactions for Therapeutic Biologics

B. Meibohm, Honghui Zhou, 2013 .

Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development

B. Meibohm, 2006 .

Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

B. Meibohm, S. Khan, M. Jaggi, 2019, Journal of colloid and interface science.

ERRATUM

B. Meibohm, 1997 .

Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis

T. Lehr, B. Meibohm, N. Hanke, 2020, Clinical Pharmacokinetics.

Pediatric Dose Selection for Therapeutic Proteins

B. Meibohm, A. Edginton, Paul R V Malik, 2021, Journal of clinical pharmacology.

Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics

B. Meibohm, M. Mandić, J. Korth-Bradley, 2017, Journal of clinical pharmacology.

Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

B. Meibohm, 2011, Clinical pharmacokinetics.

Comparative Performance of Bayesian Markov Chain Monte Carlo and Maximum Likelihood Population Estimation Methods when Applied to Nonlinear Pharmacokinetics of Monoclonal Antibodies

B. Meibohm, J. Panetta, M. Gastonguay, 2010 .

The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs

B. Meibohm, 2006 .

Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.

B. Meibohm, C. R. Yates, N. Dirks, 2004, International journal of clinical pharmacology and therapeutics.

Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration

B. Meibohm, H. Möllmann, J. Barth, 1998, European Journal of Clinical Pharmacology.

SYBR Green-based real-time PCR allelic discrimination assay for beta2-adrenergic receptor polymorphisms.

B. Meibohm, C. R. Yates, M. Gupta, 2005, Analytical biochemistry.

Dynamic time‐kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis

B. Meibohm, Richard E. Lee, A. Trivedi, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects

F. Chen, B. Meibohm, S. Laizure, 2017, British journal of clinical pharmacology.

Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties.

B. Meibohm, A. Lenaerts, M. McNeil, 2012, Bioorganic & medicinal chemistry.

Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides

B. Meibohm, Lei Diao, 2013, Clinical Pharmacokinetics.

Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies.

B. Meibohm, M. Braunstein, M. Gonzalez-Juarrero, 2019, Tuberculosis.

The clinical pharmacology of fluticasone propionate

B. Meibohm, H. Möllmann, H. Derendorf, 1998 .

Pharmacokinetics of a combination of Δ9‐Tetrahydro‐cannabinol and celecoxib in a porcine model of hemorrhagic shock

B. Meibohm, C. R. Yates, N. Mehrotra, 2011, Biopharmaceutics & drug disposition.

A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens.

B. Meibohm, N. Mehrotra, M. Christensen, 2008, Clinica chimica acta; international journal of clinical chemistry.

Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group

V. Lukacova, B. Meibohm, M. Rieder, 2015, Clinical pharmacology and therapeutics.

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.

B. Meibohm, V. Biran, J. N. van den Anker, 2019, The Journal of antimicrobial chemotherapy.

Evaluation of Vancomycin Dosing Regimens in Preterm and Term Neonates Using Monte Carlo Simulations

Lisa Tang, B. Meibohm, N. Mehrotra, 2012, Pharmacotherapy.

Population pharmacokinetic studies in pediatrics: Issues in design and analysis

Stephanie Läer, Bernd Meibohm, B. Meibohm, 2005, The AAPS Journal.

Strategic Biomarkers for Drug Development in Treating Rare Diseases and Diseases in Neonates and Infants

B. Meibohm, J. Barrett, J. Bai, 2013, The AAPS Journal.

Evaluation of regional limb perfusion with amikacin using the saphenous, cephalic, and palmar digital veins in standing horses.

B. Meibohm, A. Saxton, T. Martín-Jiménez, 2013, Journal of veterinary pharmacology and therapeutics.

The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy

B. Meibohm, A. Kovar, B Meibohm, 2007, International Journal of Impotence Research.

Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.

Duane D. Miller, B. Meibohm, J. Dalton, 2010, Journal of medicinal chemistry.

Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions.

B. Meibohm, G. Robertson, A. Lenaerts, 2017, ACS Infectious Diseases.

Pharmacokinetic aspects of biotechnology products.

B. Meibohm, A. Persky, G. Hochhaus, 2004, Journal of pharmaceutical sciences.

Gender differences in pharmacokinetics and pharmacodynamics.

H Derendorf, B. Meibohm, H. Derendorf, 1999, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama).

B. Meibohm, M. E. Prado, M. Boileau, 2011, American journal of veterinary research.

A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.

B. Meibohm, Junshu Yang, Yinduo Ji, 2017, Journal of medicinal chemistry.

Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

B. Meibohm, M. Butawan, R. Bloomer, 2017, Journal of caffeine research.

Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2

Jennifer E. Golden, B. Meibohm, C. Jonsson, 2021, Current Opinion in Virology.

Spectinamides: A New Class of Semisynthetic Anti-Tuberculosis Agents that Overcome Native Drug Efflux

B. Meibohm, M. Gonzalez-Juarrero, A. Lenaerts, 2014, Nature Medicine.

Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Stephanie Läer, Bernd Meibohm, B. Meibohm, 2008, British journal of clinical pharmacology.

SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis.

Duane D. Miller, B. Meibohm, S. White, 2022, Cancer letters.

Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction

B. Meibohm, V. Biran, E. Manolis, 2021, Clinical Pharmacokinetics.

A Modern View of Excipient Effects on Bioequivalence: Case Study of Sorbitol

A. Hussain, B. Meibohm, A. Straughn, 2006, Pharmaceutical Research.

Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort Study

Christopher R. Gignoux, M. Fornage, E. Ziv, 2012, PloS one.

Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.

Edwin K Silverman, Vilmundur Gudnason, Thomas Lumley, 2012, American journal of respiratory and critical care medicine.

From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals

F Jamali, G. Shankar, B. Meibohm, 2016, Clinical and experimental immunology.

Pharmacokinetics of intravenous amiodarone in children

B. Meibohm, T. Paul, S. Läer, 2013, Archives of Disease in Childhood.

Single‐ and Multiple‐Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes

W. Tamborlane, B. Meibohm, E. Capparelli, 2005, Journal of clinical pharmacology.

How Important Are Gender Differences in Pharmacokinetics?

Hartmut Derendorf, Bernd Meibohm, B. Meibohm, 2002, Clinical pharmacokinetics.

Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.

H Derendorf, B. Meibohm, H. Derendorf, 1997, International journal of clinical pharmacology and therapeutics.

Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives

Hartmut Derendorf, Bernd Meibohm, B. Meibohm, 1999, Pharmaceutical Research.

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

B. Meibohm, R. Braeckman, 2016 .

Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins

B. Meibohm, Yi Zhang, 2012 .

Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters.

B. Meibohm, T. Mir, S. Läer, 2002, American heart journal.

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

Duane D. Miller, B. Meibohm, C. Jonsson, 2021, J. Chem. Inf. Model..

Knowledge Sharing, and Training Are Critical for Future Success Pharmacometrics as a Discipline Is Entering the ''Industrialization'' Phase: Standards, Automation,

Hartmut Derendorf, Klaus Romero, Bernd Meibohm, 2010 .

Applied Pharmacometrics (AAPS Advances in the Pharmaceutical Sciences Series)

Bernd Meibohm, B. Meibohm, 2015, CPT: Pharmacometrics & Systems Pharmacology.

Genetic variation in antioxidant enzymes and lung function.

A. Clark, S. Kritchevsky, A. Newman, 2012, Free radical biology & medicine.

Challenges and considerations for development of therapeutic proteins in pediatric patients

B. Meibohm, J. Barrett, A. Joshi, 2015, Journal of clinical pharmacology.

Drug Development of Therapeutic Monoclonal Antibodies

D. Mould, B. Meibohm, 2016, BioDrugs.

Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology

B. Meibohm, Lei Diao, 2018, Current Pharmacology Reports.

Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy

B. Meibohm, N. Chirmule, V. Jawa, 2012, The AAPS Journal.

Characterizing the Impact of Renal Impairment on the Clinical Pharmacology of Biologics

B. Meibohm, Honghui Zhou, 2012, Journal of clinical pharmacology.

Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development

Marc Pfister, Bernd Meibohm, B. Meibohm, 2008, The AAPS Journal.

Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck

B. Meibohm, A. Kovar, N. Dirks, 2008, Journal of clinical pharmacology.

Pharmacokinetic/pharmacodynamic studies in drug product development.

Hartmut Derendorf, Bernd Meibohm, B. Meibohm, 2002, Journal of pharmaceutical sciences.

Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics of Protein Therapeutics

B. Meibohm, P. Vaddady, 2010 .

8 Pharmacokinetics Protein- and Nucleotide-Based Drugs

B. Meibohm, 2005 .

Pharmacokinetically-Guided Lead Optimization of Nitrofuranylamide Anti-Tuberculosis Agents

B. Meibohm, N. Mehrotra, Richard E. Lee, 2008, The AAPS Journal.

Discovery of novel isoxazolines as anti-tuberculosis agents.

B. Meibohm, A. Lenaerts, Dianqing Sun, 2007, Bioorganic & medicinal chemistry letters.

X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor.

Duane D. Miller, B. Meibohm, S. White, 2021, Journal of medicinal chemistry.

Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after Inhalation

B. Meibohm, H. Möllmann, H. Derendorf, 1997, Journal of clinical pharmacology.

A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids

B. Meibohm, H. Möllmann, J. Barth, 1999, Journal of Pharmacokinetics and Biopharmaceutics.

Effects of Alcohol on Human Carboxylesterase Drug Metabolism

B. Meibohm, S. Laizure, Zhe-yi Hu, 2015, Clinical Pharmacokinetics.

Pattern Recognition in Pharmacokinetic Data Analysis

Johan Gabrielsson, Bernd Meibohm, Daniel Weiner, 2015, The AAPS Journal.

The current role of model-based drug development

Liping Zhang, Marc Pfister, Bernd Meibohm, 2010, Expert opinion on drug discovery.

Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies

Weihua Li, B. Meibohm, Junhao Li, 2017, Pharmaceutical Research.

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method

Weihua Li, Bernd Meibohm, Junhao Li, 2016, PloS one.

Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.

B. Meibohm, Wenhui Zhang, T. Mir, 2005, Journal of the American College of Cardiology.

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist

B. Meibohm, S. Suryawanshi, B. Moore, 2015, Pharmacology research & perspectives.

The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease.

Yongmei Liu, S. Kritchevsky, T. Harris, 2012, The American journal of clinical nutrition.

Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score.

S. Kritchevsky, A. Newman, D. Bauer, 2006, Annals of epidemiology.

University of Groningen Genome-wide association studies identify CHRNA 5 / 3 and HTR 4 in the development of airflow obstruction

Lorna M. Lopez, A. Hofman, A. Uitterlinden, 2017 .

Pharmacokinetic profile of spectinomycin in rats.

B. Meibohm, D. Madhura, R. Lee, 2013, Die Pharmazie.

Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis

B. Meibohm, G. Robertson, A. Lenaerts, 2021, Antimicrobial agents and chemotherapy.

In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

B. Meibohm, Richard E. Lee, P. Vaddady, 2010, Future medicinal chemistry.

Ethanol Lock Therapy

B. Meibohm, M. Pourcyrous, S. Arnold, 2015, The Annals of pharmacotherapy.

Pharmaceutical biotechnology : fundamentals and applications

B. Meibohm, D. Crommelin, R. Sindelar, 2008 .

Special Section on Pediatric Drug Disposition and Pharmacokinetics Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver

B. Meibohm, E. Schuetz, R. Hines, 2016 .

Developing a Gene Expression Model for Predicting Ventilator-Associated Pneumonia in Trauma Patients: A Pilot Study

Lisa Tang, T. Fabian, B. Meibohm, 2012, PloS one.

Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric Patients

B. Meibohm, 2022, Frontiers in Pharmacology.

Novel Endogenous Glycan Therapy for Retinal Diseases: Safety, In Vitro Stability, Ocular Pharmacokinetic Modeling, and Biodistribution

B. Meibohm, Mallika Palamoor, M. Jablonski, 2014, The AAPS Journal.

Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections

B. Meibohm, J. Rosch, E. Böttger, 2015, Science Translational Medicine.

Tools for predicting the PK/PD of therapeutic proteins

Bernd Meibohm, Lei Diao, B. Meibohm, 2015, Expert opinion on drug metabolism & toxicology.

Use of Real‐World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of Age

B. Meibohm, J. Wheless, S. Phelps, 2021, Journal of clinical pharmacology.

Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypes.

B. Meibohm, G. Robertson, M. Gonzalez-Juarrero, 2023, Tuberculosis.

Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis.

B. Meibohm, M. Braunstein, C. Daley, 2021, ACS infectious diseases.

Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice.

B. Meibohm, M. Braunstein, M. Gonzalez-Juarrero, 2019, Tuberculosis.

Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success

Marc R Gastonguay, Hartmut Derendorf, Klaus Romero, 2010, Journal of clinical pharmacology.

Translational Biomarkers: from Preclinical to Clinical a Report of 2009 AAPS/ACCP Biomarker Workshop

W. Jusko, H. Eichler, F. Goodsaid, 2011, The AAPS Journal.

Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS

D. Annane, G. Chrousos, B. Rochwerg, 2020, Intensive Care Medicine.

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

Craig J. Thalhauser, Yow-Ming C Wang, A. Kierzek, 2019, Clinical and translational science.

Efficacy of a brain-penetrant antiviral in lethal Venezuelan and eastern equine encephalitis mouse models

Jennifer E. Golden, B. Meibohm, C. Jonsson, 2023, Science Translational Medicine.

Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor.

B. Meibohm, L. Gu, Mu-xiang Zhou, 2021, Journal of medicinal chemistry.

TNX-1500, an Fc-modified Anti-CD154 Antibody, Prolongs Nonhuman Primate Renal Allograft Survival.

R. Pierson, R. Colvin, B. Meibohm, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives

Bernd Meibohm, Ashit Trivedi, B. Meibohm, 2013, Expert review of clinical pharmacology.

Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure

B. Meibohm, N. Chirmule, V. Jawa, 2017, The AAPS Journal.

Drug Interactions for Therapeutic Proteins: A Journey Just Beginning

B. Meibohm, Honghui Zhou, 2013 .

Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies

Weihua Li, B. Meibohm, Junhao Li, 2017, Pharmaceutical Research.

Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599

B. Meibohm, M. Braunstein, M. Gonzalez-Juarrero, 2019, Pharmaceutical Research.

Spray dried tigecycline dry powder aerosols for the treatment of Nontuberculous mycobacterial pulmonary infections.

B. Meibohm, M. Gonzalez-Juarrero, A. Hickey, 2023, Tuberculosis.

Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs.

B. Meibohm, Richard E. Lee, N. Budha, 2008, Current medicinal chemistry.

Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo.

Duane D. Miller, Rui Wang, Wei Li, 2023, ACS pharmacology & translational science.

Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction

P. Pibarot, B. Meibohm, Ashish Sharma, 2010, Journal of clinical pharmacology.

Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics

B. Meibohm, M. Braunstein, G. Robertson, 2023, Pharmaceutics.

Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates

B. Meibohm, V. Biran, Y. Zheng, 2023, Clinical Pharmacokinetics.

Creatinine‐Based Vancomycin Dosing Regimens in Neonates: There Is More to Consider Than the Variation in Drug Assay

B. Meibohm, K. Allegaert, N. Mehrotra, 2012, Pharmacotherapy.

Genome-wide association and large scale follow-up identifies 16 new loci influencing lung function

Lorna M. Lopez, Sina A. Gharib, Bonnie R. Joubert, 2011, Nature Genetics.

Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function.

S. Kritchevsky, A. Newman, D. Bauer, 2013, Free radical biology & medicine.

PUBLISHED VERSION

Martin T. Wells, Sina A. Gharib, M. Fornage, 2014 .

Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule

Jennifer E. Golden, B. Meibohm, C. Jonsson, 2023, Clinical Pharmacokinetics.

Novel, Brain-Permeable, Cross-Species Benzothiazole Inhibitors of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Dampen Neuroinflammation In Vitro and In Vivo.

B. Meibohm, R. Bhuniya, Jianxiong Jiang, 2023, ACS pharmacology & translational science.

The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders

B. Meibohm, Qianqian Li, Jianxiong Jiang, 2023, Experimental biology and medicine.

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

Craig J. Thalhauser, Yow-Ming C Wang, A. Kierzek, 2019, Clinical and translational science.

Chapter 7. Pharmacokinetics, Drug Metabolism, and Drug Disposition

B. Meibohm, C. R. Yates, 2015 .

Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis

B. Meibohm, S. Laizure, Bing Yang, 2022, PloS one.

Pharmacokinetics and Half-Life of Protein Therapeutics

B. Meibohm, 2012 .

Pharmaceutical Biotechnology

B. Meibohm, D. Crommelin, R. Sindelar, 2013, Springer New York.

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

B. Meibohm, N. Dirks, 2010, Clinical pharmacokinetics.

Genetic ancestry in lung-function predictions.

Christopher R. Gignoux, M. Fornage, M. Nalls, 2010, The New England journal of medicine.

TNX-1500, an Fc-modified Anti-CD154 Antibody, Prolongs Nonhuman Primate Cardiac Allograft Survival.

R. Pierson, B. Meibohm, S. Lederman, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

TNX-1500, an Fc-modified Anti-CD154 Antibody, Prolongs Nonhuman Primate Renal Allograft Survival.

R. Pierson, R. Colvin, B. Meibohm, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

PUBLISHED VERSION

Trina, Charles J. Marsh, Oliver R. Wearn, 2014 .

The current role of model-based drug development

B. Meibohm, S. Suryawanshi, M. Pfister, 2010, Expert opinion on drug discovery.

Study design and simulation approach.

Stephanie Läer, Bernd Meibohm, B. Meibohm, 2011, Handbook of experimental pharmacology.

A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

B. Meibohm, S. Franzblau, A. Lenaerts, 2008, The Journal of antimicrobial chemotherapy.

Free Energy of Activation for the Comorosan Effect

B. Meibohm, G. Bass, R. Sayre, 2007, 0706.1504.

Erratum: Translational biomarkers: From preclinical to clinical a report of 2009 AAPS/ACCP biomarker workshop (AAPS Journal DOI: 10.1208/s12248-011-9265-x)

W. Jusko, H. Eichler, F. Goodsaid, 2011 .

Genome-wide association and large scale follow-up identifies 16 new loci influencing lung function

Lorna M. Lopez, Sina A. Gharib, Bonnie R. Joubert, 2011, Nature Genetics.

Large-Scale Genome-Wide Association Studies and Meta-Analyses of Longitudinal Change in Adult Lung Function

Martin T. Wells, Bonnie R. Joubert, M. Fornage, 2014, PloS one.

Colchicine-binding site agent CH-2-77 as a potent tubulin inhibitor suppressing triple-negative breast cancer.

Duane D. Miller, Hao Chen, B. Meibohm, 2022, Molecular cancer therapeutics.